China Universal Asset Management Company’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$802K Sell
44,989
-5,080
-10% -$90.9K 0.05% 225
2026
Q1
$895K Buy
50,069
+4,093
+9% +$89.5K 0.07% 205
2025
Q4
$1.24M Buy
+45,976
New +$1.29M 0.1% 168

Other funds holding CAI

China Universal Asset Management Company's CAI Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Caris Life Sciences (CAI) stake by 10% in Q2 2026, selling an estimated $90.9K and leaving 44,989 shares worth $802K. The position accounts for 0.05% of the portfolio, ranked #225.

China Universal Asset Management Company first reported a position in CAI in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.24M in Q4 2025. 44 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • China Universal Asset Management Company held 44,989 shares of Caris Life Sciences worth $802K as of Q2 2026.
  • China Universal Asset Management Company sold 5,080 Caris Life Sciences shares in Q2 2026, an estimated $90.9K.
  • Caris Life Sciences made up 0.05% of China Universal Asset Management Company's portfolio in Q2 2026, its #225 holding.
  • China Universal Asset Management Company first reported a position in Caris Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • China Universal Asset Management Company's Caris Life Sciences position peaked at $1.24M in Q4 2025.
  • 44 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.